SCHEMBL1874005

SCHEMBL1874005

NC(=O)c1ccc2occc(=O)c2c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.51
HTR1D P28221 2/20 0.51
HTR2C P28335 2/20 0.51
DYRK1A Q13627 1/20 0.49
MAOA P21397 8/20 0.47
MAOB P27338 8/20 0.47
FTO Q9C0B1 2/20 0.47
ACHE P22303 1/20 0.46
MTNR1B P49286 1/20 0.45
AR P10275 1/20 0.44
NQO2 P16083 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30768023 1.00 HTR1A (0.51) HTR1AHTR1DHTR2CDYRK1AMAOA
SCHEMBL926708 0.85 DYRK1A (0.48) DYRK1AMAOAMAOBFTOACHE
SCHEMBL30768028 0.84 TTR (0.51) DYRK1AMAOAMAOBFTOACHE
SCHEMBL6620745 0.84 TTR (0.51) DYRK1AMAOAMAOBFTOACHE
SCHEMBL3662195 0.84 DYRK1A (0.55) DYRK1AMAOAMAOBFTOACHE
SCHEMBL32670130 0.83 NPC1 (0.50) DYRK1AMAOAMAOBFTOACHE
SCHEMBL30768058 0.79 NQO2 (0.50) DYRK1AMAOAMAOBFTOACHE
SCHEMBL30768019 0.79 MAOA (0.43) HTR1AHTR1DHTR2CDYRK1AMAOA
SCHEMBL29160425 0.79 MAOA (0.43) HTR1AHTR1DHTR2CDYRK1AMAOA
SCHEMBL30768009 0.79 NQO2 (0.50) DYRK1AMAOAMAOBFTOACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117615763-A Phosphoinositide 3 kinase beta inhibitor, composition and preparation method thereof 健道生物医药有限公司 2024-02-27 CN disclosed
CN-104447657-B There is the chromene ketone derivatives of anti-tumor activity 阿斯利康(瑞典)有限公司 2016-08-17 CN disclosed
CN-102712615-A Chromenone Derivatives with Antitumor Activity ASTRAZENECA AB 2012-10-03 CN disclosed
EP-2493870-A1 CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY AstraZeneca AB (SE) 2012-09-05 EP disclosed
WO-2011051704-A1 CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2011-05-05 WO disclosed